Merck

MerckToday's Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.

www.merck.com

Merck RSS Channel

Display # 
Title Published Date
Merck launches Vivera in Latin America 20 January 2016
Merck Acquires IOmet Pharma and expands immuno-oncology development program 11 January 2016
Merck Establishes Joint Venture with Supera Farma 15 February 2012
Merck Publishes 2010 Global Corporate Responsibility Report 03 October 2011
Merck Statement on GARDASIL® 16 September 2011
Merck and Serum Institute Announce Collaboration 12 August 2011
ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor 01 October 2010
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication SAPHRIS® 09 September 2010
Merck Provides New Funding to Fight HIV/AIDS in Botswana 25 August 2010
Single Treatment with ELONVA® Produced Live Birth Rates Comparable to Daily rFSH Injections 30 June 2010
New SIMPONI (Golimumab) Data Shows Sustained Efficacy in the Treatment of Rheumatoid Arthritis 23 June 2010
Merck Announces Launch of Pioneering Collaborative Cancer Trials Network 04 June 2010
Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology 26 May 2010
Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy 12 May 2010
Merck Announces First-Quarter 2010 Financial Results 05 May 2010
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA® 23 November 2009
New Merck Begins Operations 05 November 2009
Merck and Schering-Plough to Merge 10 March 2009
Two Merck Medicines Recommended for Approval in the European Union 25 April 2008
Merck & Co., Inc. Announces Completion of NovaCardia, Inc. Acquisition 13 September 2007

Most Popular Now

Pandemic influenza vaccine receives…

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europe...

Read more

NIH launches large clinical trials …

Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection. Known as the A...

Read more

World's first public dengue immuniz…

Sanofi and its vaccines global business unit Sanofi Pasteur announced today that the first public dengue immunization program has started in the Philippines. At a major l...

Read more

Saxenda® demonstrated significant i…

Today, new data from the three-year part of the phase 3a SCALE™ (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial were presented at th...

Read more

AstraZeneca and Eli Lilly and Compa…

AstraZeneca and Eli Lilly and Company today announced that AMARANTH, a Phase II/III study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in...

Read more

Vitamin D improves heart function, …

A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found. Dr Klaus Witte, from ...

Read more

Pfizer announces termination of pro…

Pfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The deci...

Read more

New analysis shows only minority of…

Boehringer Ingelheim has announced a new publication showing that levels of white blood cells called eosinophils can help identify patients with COPD who may and may not ...

Read more

Researchers open the way to new tre…

In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length struc...

Read more

Implantable device targets pancreat…

Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, whi...

Read more

Physicians' knowledge about FDA app…

Since 2012, the FDA can designate a drug as a "breakthrough therapy" if preliminary clinical evidence - such as an improvement in a pharmacodynamic biomarker - suggests a...

Read more

Global spending on health is expect…

Global inequities in health spending are expected to persist and intensify over the next 25 years, according to a new study that estimates total health financing in count...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]